U.K. expands COVID-19 mix and match vaccine trial
Published
The Com-Cov study, led by the University of Oxford, has been investigating the immune responses of volunteers given a dose of the Oxford/AstraZeneca vaccine followed by the Pfizer jab, and vice-versa, since February.
Full Article